Gamestop (GME) Up / Abercrombie (ANF) Down; Newsflash - Teens Are Fat
Tweet
Share
E-mail.jpg)
Get Alerts GME Hot Sheet
Price: $21.14 -1.77%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 13.9%
EPS Growth %: -24.0%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 13.9%
EPS Growth %: -24.0%
Join SI Premium – FREE
Shares of Abercrombie & Fitch Co. (NYSE: ANF) declined on Thursday in the wake of disappointing Q2 results and guidance. Meanwhile, GameStop Corp. (NYSE: GME) shares moved higher after reporting better than expected results over the same period.
Interestingly, Abercrombie's management had no explanation for the trouble it and other teen retailers are facing. American Eagle Outfitters (NYSE: AEO) and Aeropostale, Inc. (NYSE: ARO) also reported disappointing results recently. Given impressive Gamestop results, clearly teens are spending, but apparently not on clothing.
Against this backdrop, there is some speculation on the Street that the decline is related to the growing number of overweight teens. There are no hard facts linking the decline in sales among teen apparel retailers to obesity, but a few traders believe there is a link. According to American heart associations, 1-in-3 teens are overweight.
Interestingly, Abercrombie's management had no explanation for the trouble it and other teen retailers are facing. American Eagle Outfitters (NYSE: AEO) and Aeropostale, Inc. (NYSE: ARO) also reported disappointing results recently. Given impressive Gamestop results, clearly teens are spending, but apparently not on clothing.
Against this backdrop, there is some speculation on the Street that the decline is related to the growing number of overweight teens. There are no hard facts linking the decline in sales among teen apparel retailers to obesity, but a few traders believe there is a link. According to American heart associations, 1-in-3 teens are overweight.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Regenxbio shares jump after FDA agrees to reverse drug rejection
- Apollo Private Credit Fund caps redemptions at 5% - Bloomberg
Create E-mail Alert Related Categories
Insiders' Blog, Retail Sales, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
